Genmab — April 2021
-
God morgen.
-
Asien: Frygt for nye nedlukninger presser japanske selskaber https://www.proinvestor.com/investornyt/674191/asien-frygt-for-nye-nedlukninger-presser-japanske-selskaber
-
Genmab/DNB: Kursmål løftet 9 pct. https://www.proinvestor.com/investornyt/674193/genmab-dnb-kursmal-loftet-9-pct-gent
-
Tirsdagens danske avisuddrag med Danske Bank, Lego og Hummel https://www.proinvestor.com/investornyt/674194/tirsdagens-danske-avisuddrag-med-danske-bank-lego-og-hummel
-
God morgen
-
Genmab/Deutsche Bank: Indleder med "køb" og kursmål på 2750 kr. https://www.proinvestor.com/investornyt/674199/genmab-deutsche-bank-indleder-med-kob-og-kursmal-pa-2750-kr
-
Aktier/tendens: Genmab, Netcompany og banker i fokus på stille dag https://www.proinvestor.com/investornyt/674201/aktier-tendens-genmab-netcompany-og-banker-i-fokus-pa-stille-dag
-
Umiddelbart virker det til, at kontrakten er lavet over en slags standardformular for royalty agreements. Mange af kontraktens specifics er overstregede - og offentligheden har derfor ikke adgang til den egentlige ordlyd. Enhver vurdering af sagen lader til at være mere holdning end egentlig substans
-
Nogen må have moret sig bekosteligt den første time her til morgen
-
that is fast for a change...: NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta https://pharmaphorum.com/news/nice-says-yes-to-novartis-multiple-sclerosis-therapy-kesimpta/
(15:12)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind